Use of the glutoxim drug in the complex treatment of combined infection of tuberculosis and new coronavirus infection

The article discusses the problem of combined infection of tuberculosis and new coronavirus infection during the pandemic. The search for effective means for the treatment of patients with tuberculosis and new coronavirus infection, as well as the prevention of complications of these diseases is a priority for phthisiologists and infectious disease specialists. The class of regulators of the body's internal defense systems, according to their pharmacological activity, belong to antibiotic adjuvants. A representative of this class is the domestic Glutoxim drug. The main pharmacological effects of this drug are the antimicrobial therapy enhancement, including increasing the availability of the microorganism (pathogen) to the action of drugs and, subsequently, overcoming the drug resistance of microorganisms, as well as eliminating the imbalance of redox homeostasis. The article shows the effectiveness of Glutoxim in the treatment of patients with tuberculosis and new coronavirus infection.